Medicine

Trine Andresen, J. Agúndez, Hela Nazari, Vibeke Andersen

2026.2.24PHARMACOGENOMICS JOURNAL

DOI: 10.1038/s41397-026-00400-w

tlooto-Zusammenfassung

The possibilities of pharmacogenetic testing as a supportive clinical decision tool to optimize treatment and minimize risk of e.g., serious adverse effects, remission, and other serious complications are shown.

Abstract

Abstract ist nicht verfügbar.

Zitationsformat

ANDRESEN, Trine, et al. Potential of pharmacogenetics in treatment of chronic inflammatory diseases – a danish report overview from 2000 – 2024. PHARMACOGENOMICS JOURNAL, 2026, 26(2).